• 1 out of 1 points
When an unstable patient asks why it is necessary to add
medications to his current regimen, the PMHNP’s best response
would be:
Selected C.
Answer: “Many psychiatric illnesses involve several dys-functioning neurotransmitter systems in
the brain. Often, a single medication may only effect one or two of the dys-functioning
systems. The addition of another medication can work with the current medication in
stabilizing multiple neurotransmitter systems and help to alleviate your symptoms.”
• Questio
n2 0 out of 1 points
The PMHNP is meeting with a new mother who would like to begin
taking medication again to treat her bipolar depression; she is
breastfeeding her 2-month old daughter. The PMHNP recognizes
that which of the following medications is contraindicated for this
patient?
Selected C.
Answer:
Lithium
(Lithobid)
• Questio
n3 1 out of 1 points
Mr. Gordon is a middle-aged client who was started on
antidepressant monotherapy for depression. After beginning this
medication, the PMHNP noticed that this client seemed to swing
into a hypomanic episode. What can the PMHNP infer from this
behavior change?
, Selected A.
Answer:
This client may have Bipolar III disorder
• Questio
n4 1 out of 1 points
A patient presents with frequent episodes of mania. Which
statement describes an appropriate treatment approach for this
patient?
Selected B.
Answer:
“The patient could benefit from an
anticonvulsant.”
• Questio
n5 1 out of 1 points
The student inquires about antipsychotic medications. Which
, response by the PMHNP describes the factors that contribute to
reduced risk of extrapyramidal symptoms (EPS) for patients who
take antipsychotics?
Selected B.
Answer:
Those that are potent D2 antagonists with 5HT2A
antagonism properties
• Questio
n6 1 out of 1 points
After ordering flumazenil (Rumazicon) the PMHNP cautions the staff to
monitor for which possible effect?
Selected D.
Answer:
All of
the
above
• Questio
n7 1 out of 1 points
The PMHNP is caring for a patient who is taking antipsychotics
heard the psychiatrist tell the patient that the patient would be
placed on a different antipsychotic agent called an atypical
antipsychotic. What neurotransmitters will this new medication
work on?
Selected A.
Answer:
dopamine and serotonin
• Questio
n8 1 out of 1 points
, While genes have potential to modify behavior, behavior can also
modify genes. How do genes impact this process?
Selected B.
Answer:
Changes made to proteins lead to changes in
behavior.
• Questio
n9 1 out of 1 points
Mrs. Schwartzman is a 52-year-old client with schizophrenia and
no established history of depression. When meeting with the
PMHNP, she presents with apathy and withdrawn social behavior,
and she reports a loss of joy from enjoyable activities since
starting her new medication. What does the PMHNP infer from this
encounter with the client?
Selected C.
Answer:
The new medication is blocking D2 receptors in the
mesolimbic system
When an unstable patient asks why it is necessary to add
medications to his current regimen, the PMHNP’s best response
would be:
Selected C.
Answer: “Many psychiatric illnesses involve several dys-functioning neurotransmitter systems in
the brain. Often, a single medication may only effect one or two of the dys-functioning
systems. The addition of another medication can work with the current medication in
stabilizing multiple neurotransmitter systems and help to alleviate your symptoms.”
• Questio
n2 0 out of 1 points
The PMHNP is meeting with a new mother who would like to begin
taking medication again to treat her bipolar depression; she is
breastfeeding her 2-month old daughter. The PMHNP recognizes
that which of the following medications is contraindicated for this
patient?
Selected C.
Answer:
Lithium
(Lithobid)
• Questio
n3 1 out of 1 points
Mr. Gordon is a middle-aged client who was started on
antidepressant monotherapy for depression. After beginning this
medication, the PMHNP noticed that this client seemed to swing
into a hypomanic episode. What can the PMHNP infer from this
behavior change?
, Selected A.
Answer:
This client may have Bipolar III disorder
• Questio
n4 1 out of 1 points
A patient presents with frequent episodes of mania. Which
statement describes an appropriate treatment approach for this
patient?
Selected B.
Answer:
“The patient could benefit from an
anticonvulsant.”
• Questio
n5 1 out of 1 points
The student inquires about antipsychotic medications. Which
, response by the PMHNP describes the factors that contribute to
reduced risk of extrapyramidal symptoms (EPS) for patients who
take antipsychotics?
Selected B.
Answer:
Those that are potent D2 antagonists with 5HT2A
antagonism properties
• Questio
n6 1 out of 1 points
After ordering flumazenil (Rumazicon) the PMHNP cautions the staff to
monitor for which possible effect?
Selected D.
Answer:
All of
the
above
• Questio
n7 1 out of 1 points
The PMHNP is caring for a patient who is taking antipsychotics
heard the psychiatrist tell the patient that the patient would be
placed on a different antipsychotic agent called an atypical
antipsychotic. What neurotransmitters will this new medication
work on?
Selected A.
Answer:
dopamine and serotonin
• Questio
n8 1 out of 1 points
, While genes have potential to modify behavior, behavior can also
modify genes. How do genes impact this process?
Selected B.
Answer:
Changes made to proteins lead to changes in
behavior.
• Questio
n9 1 out of 1 points
Mrs. Schwartzman is a 52-year-old client with schizophrenia and
no established history of depression. When meeting with the
PMHNP, she presents with apathy and withdrawn social behavior,
and she reports a loss of joy from enjoyable activities since
starting her new medication. What does the PMHNP infer from this
encounter with the client?
Selected C.
Answer:
The new medication is blocking D2 receptors in the
mesolimbic system
